论文部分内容阅读
β受体阻滞剂自20世纪60年代以来已广泛用于临床,在高血压、冠状动脉粥样硬化性心脏病(冠心病)、心力衰竭、心律失常、心肌病等心血管疾病的防治领域中具有重要的作用。β受体阻滞剂用于高血压的治疗已有四十多年的历史,1978年世界卫生组织正式将其列为高血压治疗的一线药物,以后各国高血压防治指南均推荐β受体阻滞剂作为降压一线药物或主要药物。200
β blockers have been widely used clinically since the 1960s and have been widely used in the prevention and treatment of cardiovascular diseases such as hypertension, coronary atherosclerotic heart disease (CHD), heart failure, arrhythmia and cardiomyopathy In the important role. β blockers for the treatment of hypertension has been more than 40 years of history, the World Health Organization in 1978 formally listed as first-line treatment of hypertension drugs, after the guidelines for the prevention and treatment of hypertension in all countries are recommended β-blocker Antidepressants as a first-line antihypertensive drugs or the main drug. 200